Mark W. Tyndall

Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work.

M. Tyndall, J. Shoveller, K. Shannon, 2008, The International journal on drug policy.

Preliminary development of a scale to measure stigma relating to sexually transmitted infections among women in a high risk neighbourhood

M. Tyndall, J. Shoveller, M. Rusch, 2008, BMC women's health.

Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control

M. Schechter, M. Tyndall, Kathy Li, 2002, Sexually transmitted infections.

A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya.

S. Moses, K. MacDonald, F. Plummer, 1999, The Journal of infectious diseases.

Injection drug use cessation and use of North America ’ s first medically supervised safer injecting facility

Julio S. G. Montaner, E. Wood, T. Kerr, 2010 .

Hospital utilization and costs in a cohort of injection drug users.

M. Schechter, A. Anis, A. Palepu, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Health and Social Services Accessed by a Cohort of Canadian Illicit Opioid Users Outside of Treatment

J. Rehm, N. el-Guebaly, T. Wild, 2006, Canadian journal of public health = Revue canadienne de sante publique.

Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users

T. Kerr, M. Tyndall, K. Shannon, 2006, Harm reduction journal.

The end of the line: has rapid transit contributed to the spatial diffusion of HIV in one of Canada's largest metropolitan areas?

R. Hogg, J. Montaner, M. Schechter, 2000, Social science & medicine.